Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000050

Director bought 18,400 shares at an average $0.62 ($11,442)

From the SEC's structured data for this filing

Trades in this filing

SPRINGER TIMOTHY A · Director

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-17 Purchase : show line 1 in the form +800 $0.69 $552 87,218 I
2024-02-06 Purchase : show line 2 in the form +800 $0.65 $520 88,018 I
2024-02-07 Purchase : show line 3 in the form +2,400 $0.66 $1,575 90,418 I
2024-03-08 Purchase : show line 4 in the form +4,800 $0.66 $3,187 95,218 I
2024-03-11 Purchase : show line 5 in the form +1,200 $0.65 $785 96,418 I
2024-03-12 Purchase : show line 6 in the form +1,200 $0.61 $735 97,618 I
2024-03-13 Purchase : show line 7 in the form +3,200 $0.58 $1,868 100,818 I
2024-03-14 Purchase : show line 8 in the form +2,000 $0.53 $1,061 102,818 I
2024-03-15 Purchase : show line 9 in the form +1,200 $0.56 $672 104,018 I
2024-03-18 Purchase : show line 10 in the form +800 $0.61 $488 104,818 I
Open-market purchases · 18,400 sh · avg $0.62 · $11,442
Loading xslF345X05/wk-form4_1711660282.xml…